Published in Cancer Weekly, September 25th, 2007
"Many reports have explored the role of Ell expression in the repair mechanism of cisplatin-induced DNA adducts in cancer cells. Recent findings Using immunohistochemistry in resected tumors, the International Adjuvant Lung Cancer Trial showed that high ERCC1 protein expression was associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.